Introduction
T he exact mechanism behind the development of hypospadias is unclear, despite it being a common congenital anomaly in boys. [1] [2] [3] Several reports have shown an increase in the incidence of hypospadias over the last 30 years. It is thought that hypospadias is caused by genetic susceptibility in combination with adverse environmental exposure, which disrupts the balance of androgens and estrogens required for normal sexual differentiation of the external genitalia. [4] [5] [6] [7] [8] Androgens are essential for the formation of the male urogenital system. Hence, any defect in the androgen expression in the different types of hypospadias. In this study, we have analyzed AR expression and hormone levels in hypospadias patients and compared them with children having normal genitalia.
Methods
This was a prospective study commenced after taking permission from the institutional ethics committee. Informed consent was obtained from the patients, and complete confidentiality was maintained with regard to the clinical details. Group 1 (controls) involved children with normal genitalia (who underwent circumcision for phimosis), while Group 2 involved hypospadias patients, with bilateral descended testis, who did not receive any preoperative testosterone. Preoperative hormonal assay included luteinizing hormone (LH), follicle-stimulating hormone (FSH), and free testosterone (fTST) levels in all the patients.
The foreskin collected during surgery was fixed in formalin, paraffin embedded, and sectioned. The foreskin specimens were analyzed for AR expression using immunohistochemistry (anti-AR antibody PathnSitu, clone R441, 1/100 dilution). AR staining was expressed as H score which was calculated by multiplying the intensity of staining and the percentage of stained cells showing cytoplasmic positivity [ Figure 1 ] at high power (×40). A total of 100 cells were counted at high power, and the intensity of AR expression was scored 0, 1, 2, and 3 based on the intensity of staining (brown). The total H score was calculated by multiplying the cell score and the number of cells, with a maximum score 300 if all 100 cells scored 3.
The mean H score was compared between hypospadias patients and controls using Student's t-test. A similar comparison was made between distal and proximal hypospadias patients. The difference was considered statistically significant if P < 0.05.
Results
There were 27 patients in Group 1 and 16 in Group 2. In Group 2, six patients had proximal hypospadias while ten had distal hypospadias. The mean age (range) of the boys in Group 1 was 23 months at the time of surgery, while 27 months (12-34) in Group 2. There was no significant difference between the groups. The mean serum FSH level was 0.9 IU/I in Group 1 compared to 0.8 IU/I in Group 2. The mean serum LH level was 0.85 IU/I in Group 1 and 1.1 IU/I in Group 2. The mean fTST level was 6.4 ng/dL in Group 1 and 6.9 ng/dL in Group 2. There was no significant difference in the hormone levels between the groups. Figure 2 represents the mean H score between the groups. It was significantly higher (P = 0.001) in hypospadias patients (189.5) compared to controls (97.5). Figure 3 represents the mean (standard deviation) H score between proximal and distal hypospadias. It was significantly higher (P = 0.01) in proximal (220) compared to distal (159) hypospadias.
Discussion
Hypospadias is one of the most common congenital malformations occurring in boys. Hypospadias is considered a multifactorial disorder since both genetic and environmental factors are involved. [1, 2] Maternal exposure to chemical pollutants or high concentrations of endocrine disruptors in selected occupations/ geographic areas may be additional risk factors for hypospadias. Although in most cases the etiology is unknown, hypospadias has been associated with aberrant androgen signaling during development. [3, 4] Interferences in the androgen metabolism, for example, 5α-reductase deficiency, or defects of the AR and its genes are possible etiological factors for hypospadias in a small proportion of patients. [5, 6] Androgen signaling through the AR is critical for normal penile development. Diminished androgen signaling results in a spectrum of incompletely virilized external genitalia: complete androgen insensitivity results in female external genitalia while partial insensitivity results in ambiguous genitalia of varying degrees. AR plays a crucial role in male sex differentiation by mediating the biological effects of androgens. The AR gene resides on chromosome Xq11-12. [5] [6] [7] [8] 21] Pichler et al. [9] and Baskin [10] reported quantitative measurement of differences in the AR in the discarded foreskin collected at the time of surgical repair in boys with hypospadias and compared it with that of a cohort undergoing circumcision. We performed a similar study in Indian children, and our findings are similar to these studies. ARs are overexpressed in hypospadias boys compared to controls, and this overexpression was higher in those with severe hypospadias.
The mechanism of this overexpression may be through the genetic pathway ZEB1, which is known to be estrogen responsive, and may be an important mediator of estrogen-driven aberrant androgen signaling in hypospadias. [11, 12] It is still unclear whether the overexpression of AR is a cause of hypospadias or an effect of exposure to estrogens like compounds during fetal life. There are several other studies with conflicting reports on AR expression. [13] [14] [15] [16] [17] [18] [19] [20] Although none of our patients reported any medical/chemical exposure to estrogenic compounds, we could not rule out maternal exposure to estrogens like compounds common in pesticide-contaminated fruits/vegetables. There was no significant difference in serum-free testosterone, LH, and FSH levels between the groups in our study, indicating the absence of any hormonal dysfunction.
Agras et al. [22] evaluated the influence of exogenous estrogen. Their quantitative results indicated that developing females expressed higher levels of AR than males throughout ontogeny. AR expression in the genital tubercle increased in response to in utero estrogen exposure with estrogen-treated females having the highest AR expression, followed by estrogen-treated males with hypospadias. These findings could be the result of relatively lower levels of androgens in female genital tubercles, indicating that the organism is trying to compensate for lower levels of androgens by increasing AR expression. The organism reacted by upregulating AR expression so that it could respond better to any androgen that might have still been present.
The pitfalls of this study are small numbers. Further larger trials are likely to throw more light into the etiopathogenesis of these complex malformations. We have analyzed only those patients who did not undergo preoperative testosterone treatment. Further studies could address whether testosterone supplementation could up/downregulate AR expression. Furthermore, further studies could address whether prior knowledge of AR status could determine testosterone resistance, noted in some patients with severe hypospadias.
Conclusion
The results of our study show that AR expression was significantly elevated in hypospadias patients. It was higher in proximal compared to distal hypospadias, probably due to end-organ overexpression.
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